Slideshow

Depression Research Update: July 2018

Author(s):

Mark L. Fuerst

Highlights of 3 new studies investigate how to choose the best therapy for depression as well as the negative influences of polypharmacy and social media.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!
Related Videos
McIntyre
John Krystal
Related Content
depression
August 14th 2025

FDA Grants Fast Track Designation for NRX-100 for Suicidal Ideation in Patients With Depression, Including Bipolar Depression

Leah Kuntz
Blue Light Blockers: A Behavior Therapy for Mania
August 14th 2025

Blue Light Blockers: A Behavior Therapy for Mania

Chris Aiken, MD Kellie Newsome, PMH-NP
neurodevelopmental disorder suicide risk
August 14th 2025

Suicide Risk Screening for Children With Neurodevelopmental Disabilities: New Insights

Suzanne Rybczynski, MD, MSHCM
Blue Light, Depression, and Bipolar Disorder
August 14th 2025

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
depression prescription
August 14th 2025

Advantage of Augmenting Antidepressant Over Switching Qualified in New Analysis

Kenneth J. Bender, PharmD, MA
MAOIs
August 14th 2025

Successfully Prescribing MAOIs for Depression

Shalom Feinberg, MD
© 2025 MJH Life Sciences

All rights reserved.